Royal Bank Of Canada Spectrum Pharmaceuticals Inc Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.65 - $1.31 $4,754 - $9,581	-7,314 Reduced 99.95%	4 $0
Q1 2023 May 15, 2023	BUY	$0.38 - $1.07 $2,505 - $7,055	6,594 Added 910.77%	7,318 $5,000
Q4 2022 Feb 14, 2023	BUY	$0.32 - $0.52 $5 - $8	17 Added 2.4%	724 $0
Q3 2022 Nov 14, 2022	BUY	$0.43 - $1.56 $284 - $1,031	661 Added 1436.96%	707 $0
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.4 $6,995 - $13,991	-9,994 Reduced 99.54%	46 $0
Q1 2022 May 16, 2022	SELL	$0.63 - $1.59 $15,089 - $38,082	-23,951 Reduced 70.46%	10,040 $13,000
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.42 $24,350 - $46,401	19,174 Added 129.41%	33,991 $43,000
Q3 2021 Nov 15, 2021	BUY	$2.15 - $3.82 $9,083 - $16,139	4,225 Added 39.89%	14,817 $33,000
Q2 2021 Aug 16, 2021	BUY	$2.89 - $4.45 $30,610 - $47,134	10,592 New	10,592 $40,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.